Citations

Clear

4610 citation(s) found for "Lu, Brian".

Mixed Adenosquamous Cell Carcinoma of the Prostate with Paired Sequencing on the Primary and Liver Metastasis
Oyogoa, Emmanuella, Sonpatki, Maya, Brinkerhoff, Brian , Andeen, Nicole K. , Meyer, Haley , Ryan, Christopher W. , Sokolova, Alexandra

Mayo Clinic

Current Oncology | April 24, 2024 | Volume: 31 | Issue: 5 | Pages: 2393-2399

10.3390/curroncol31050178 | PMID 38785459 Get It

This report aims to shed light on the intricate challenges encountered during the diagnosis and treatment of an uncommon variant of prostate cancer—mixed adenosquamous cell carcinoma of the prostate. Prostate cancers of this nature pose distinctive diagnostic and therapeutic dilemmas due to their rarity and complex histological composition. We present a case of a 63-year-old man with metastatic prostate cancer, featuring adenocarcinoma with squamous cell differentiation, who underwent a multimodal treatment approach. The patient responded to first-line carboplatin, docetaxel, and androgen deprivation therapy, followed by androgen receptor pathway inhibitor (ARPI) maintenance. However, disease progression led to radiation therapy and a subsequent switch to Lutetium (177Lu) vipivotide tetraxetan after chemotherapy challenges. Comprehensive genetic profiling revealed shared mutations in the prostate and liver lesions, emphasizing the role of targeted therapies. Prostate-specific membrane antigen (PSMA)-targeted therapy resulted in a notable PSA decline. This case highlights the evolving treatment landscape for rare prostate cancers, integrating genetic insights for tailored interventions. In conclusion, squamous cell carcinoma (SCC) of the prostate is rare, emphasizing the imperative for enhanced comprehension in diagnosis and management. Our case suggests the potential efficacy of ARPI and PSMA-targeted therapies. Our findings advocate for a more nuanced approach to the management of this rare prostate cancer variant, leveraging genomic insights for personalized treatment strategies. This exploration serves as a foundation for further research and clinical considerations in addressing the challenges posed by mixed adenosquamous cell carcinoma of the prostate.
Abstract 342: Comparison of Fractional Flow Reserve (FFR) and Cardiac Stress Testing in Prediction of Coronary Ischemia
Shahrivari, Mahan, Kurklinsky, Andrew K., Levy, Michael , Shapiro, Brian P. , Moussa, Issam , Kumar, Preetham

Mayo Clinic

Circulation | April 23, 2024 | Volume: 128 | Issue: suppl_22 | Pages: No page available

10.1161/circ.128.suppl_22.a342 Get It

Introduction: Clinical outcomes of FFR-guided PCI have been superior to those of angiographically guided PCI, with or without prior cardiac stress testing. Based on these findings, we hypothesized that the accuracy of stress testing is inferior to that of FFR in determining the physiologic significance of angiographic coronary artery disease. Method: To that end, we studied 243 consecutive patients who underwent coronary angiography and FFR assessment between September 2010 and April 2013 at Mayo Clinic, Florida. Out of this group, we excluded 143 patients due to absence of stress testing in the preceding 6 months. We assessed demographics, coronary risk factors, symptoms, stress test variables, angiographic data, and FFR measurements. FFR values ≤0.80 were considered to be positive for ischemia. We evaluated the diagnostic performance of stress testing vs. FFR. Result: Out of the 100 patients included in the study, FFR was measured in the Left Main coronary artery in 3(3%), in the Left Anterior Descending artery (LAD) in 67(67%), in the left circumflex territory in 11(11%), in the Right Coronary Artery (RCA) in 18(18%). The diagnostic performance of stress testing vs. FFR is summarized in the table, with regards to presence of ischemia in any vascular territory and with regards to a specific vascular territory. Conclusion: Compared to FFR, cardiac stress testing has reasonable NPV but poor PPV in determining the presence of absence of overall ischemia in a given patient. Most concerning, however, is that stress testing has poor PPV and NPV when used to determine the site of ischemia in a specific vascular territory.
Abstract 18185: Regression of Severe Left Ventricular Hypertrophy After Transcatheter Valve Replacement for Aortic Stenosis: Impact on Clinical Outcomes in PARTNER Cohort A
Stewart, William C. , Weissman, Neil J., McAndrew, Thomas , Szeto, Wilson Y, Makkar, Raj , Babaliaros, Vasilis , Bowers, Bruce, Greason, Kevin L. , Leon, Martin B, Devereux, Richard B, Lindman, Brian R. , Stewart, William, Pibarot, Phillippe , Hahn, Rebecca T , Szeto, Wilson Y, Miller, D. Craig , Kapadia, Samir , Leon, Martin B, Enriquez‐Sarano, Maurice , Devereux, Richard B, Otto, Catherine M , Douglas, Pamela S.

Mayo Clinic

Circulation | April 23, 2024 | Volume: 128 | Issue: suppl_22 | Pages: No page available

10.1161/circ.128.suppl_22.a18185 Get It

Background: Left ventricular (LV) mass regression after aortic valve replacement (AVR) for aortic stenosis (AS) is a favorable effect of LV unloading, but its relationship to improved clinical outcomes is unclear. We examined the effect on clinical outcomes after transcatheter AVR (TAVR) of: 1) amount of LV mass index (LVMi) regression; and 2) persistent severe LV hypertrophy (LVH). Methods: Of 2115 patients with symptomatic AS at high surgical risk receiving TAVR in the PARTNER randomized trial or continued access registry, 462 (55% women) who had severe LVH (LVMi ≥149 g/m 2 men, ≥122 g/m 2 women, by ASE criteria) at baseline (BL) and LVMi measured 6 mo post-TAVR were included in our analysis. The effect of LVMi regression was evaluated by comparing outcomes in patients with greater vs. lesser decrease (dichotomized by median % change) in LVMi between BL and 6 mo, and in those without vs. with persistent severe LVH 6 mo post-TAVR. Cox PH models evaluated rates of all-cause mortality (6-12 mo), rehospitalizations (through 1 yr), and the composite of these two outcomes. Results: LVMi decreased from 173±32 (BL) to 121±25 g/m 2 (6 mo) (p<0.001) in those with greater LVMi regression, and from 164±30 (BL) to 158±34 g/m 2 (6 mo) (p<0.001) in those with lesser LVMi regression. Patients with greater vs. lesser LVMi regression had similar baseline clinical characteristics, a lower rate of rehospitalization (10.5% vs. 19.9%, p=0.006) and lower rate of the composite endpoint of death or rehospitalization (13.2% vs. 21.4%, p=0.02), but a similar rate of death (4.9% vs. 4.8%, p=0.86). Persistent severe LVH at 6 mo post-TAVR was present in 54% (58% of whom were women). Patients without vs. with persistent severe LVH had similar baseline clinical characteristics, a lower rate of rehospitalization (11.9% vs. 18.1%, p=0.053) and lower rate of the composite endpoint of death or rehospitalization (13.3% vs. 20.7%, p=0.03), but a similar rate of death (3.9% vs. 5.7%, p=0.42). Similar results were obtained when including patients with moderate or severe LVH. Conclusions: In high-risk patients with severe AS and severe LVH undergoing TAVR, greater LV mass regression and resolution of initially severe LVH at 6 months are associated with a lower rate of death or repeat hospitalization.
Abstract 13852: Improved Long-Term Survival With Repeat Coronary Bypass Surgery Compared to Percutaneous Coronary Intervention After Previous Surgical Revascularization a 20 Year Experience
Greiten, Lawrence E. , Stulak, John M., Greason, Kevin L. , Daly, Richard C. , Joyce, David L. , Maltais, Simon, Lahr, Brian D. , Heins, Courtney N., Locker, Chaim, Schaff, Hartzell V. , Said, Sameh M. , Dearani, Joseph A. , Lerman, Amir

Mayo Clinic

Circulation | April 23, 2024 | Volume: 134 | Issue: suppl_1 | Pages: No page available

10.1161/circ.134.suppl_1.13852 Get It

Introduction: We compared outcome of repeat CABG (RCABG) and PCI in patients with previous CABG. Hypothesis: RCABG may improve survival versus PCI. Methods: From 1993 through 2009, 3,058 patients underwent revascularization after previous CABG. RCABG patients (n=530) were grouped by the use of arterial grafts (n=396), or saphenous vein grafts (SVG; n=134). At previous CABG, 37% of RCABG patients received IMA graft. PCI patients (n=2,528) were grouped into balloon angioplasty (BA; n=491), bare metal stent (BMS; n=1,267), and drug-eluting stent (DES; n=769). PCI patients were further stratified by the treated target into native coronary artery (n=1,637), bypass grafts (n=674), or both (n=216). Propensity score analysis matched 287 patients. Results: RCABG had increased 30-day mortality compared with PCI (HR=3.92; 95% CI, 2.25-6.84; P <.001) in multivariable analysis, while in propensity matched analysis it did not ( P =.09). Overall survival, however, was greater for RCABG compared with PCI in multivariable analysis (HR=0.70; 95% CI, 0.59-0.83; P <.001), as well as in propensity matched analysis (10-year survival rates were 52% vs 37%, respectively [ P =.005]). Compared with RCABG, PCI involving bypass grafts had increased mortality (HR, 1.39; 95% CI, 1.09-1.78; P =.008), whereas PCI targeting only the native coronaries did not (HR, 1.12; 95% CI, 0.85-1.47; P =.43); BMS patients had increased mortality (HR, 1.34; 95% CI, 1.06-1.68; P =.013), but DES did not (HR, 1.28; 95% CI, 0.77-2.12; P =.35). At RCABG, 318 patients (60%) received an IMA graft and late survival was similar to those receiving SVG; The use of IMA in previous CABG was associated with improved survival (HR=0.82; 95% CI, 0.72-0.92; P <.001]. Conclusions: Long-term survival after previous CABG is improved with RCABG compared to PCI, especially when PCI involves bypass grafts. There is no difference in long-term survival between RCABG using arterial grafts vs SVG only if IMA is used in either previous or RCABG.
Abstract 281: Does Chest Compression-Only CPR Provide Meaningful Gas Exchange in Humans?
Roosa, Jason, Kitamura, Brian, McCarty, Kyle, Page, Rianne, Roque, Pedro, Silver, Annemarie, Stolz, Uwe, Vadeboncoeur, Tyler F. , Bobrow, Bentley J., Group, SHARE Study, Spaite, Daniel W. , Group, SHARE Study

Mayo Clinic

Circulation | April 23, 2024 | Volume: 126 | Issue: suppl_21 | Pages: No page available

10.1161/circ.126.suppl_21.a281 Get It

Background: During CPR in animals, chest compressions (CC) may produce passive volumes large enough to provide adequate ventilation. In humans, this mechanism may explain why continuous CCs have been associated with improved survival. We quantified the volume of passive ventilation during emergency department (ED) CCs to determine if compression-only CPR (COCPR) provides clinically significant gas exchange during resuscitation. Methods: In an urban ED, continuous flow and volume of air exhaled through an endotracheal tube were measured during the CC phase of manual CPR (between ventilations) with NICO monitors (Philip/Respironics) and recorded using LabView (National Instruments). Gas exchange with CC was quantified using Matlab (Mathworks) as the area under the flow curve (figure). CC quality was measured using accelerometer-based technology (R Series, ZOLL Medical). Results: Eight patients (6 male) aged 37-83 yrs [median age 51 yr (IQR 43-56)] who suffered out-of-hospital cardiac arrest (CA) and were transported and treated with CC in the ED were included. A total of 548 CCs [median depth 1.89 in (IQR=1.66, 2.29), median rate 128 CC/min (IQR=122-134) were analyzed over 30 min of CPR. Median tidal volume per CC was 17.3 mL (IQR=5.9-22.4). This was considerably less than measured dead space in all patients (median 118mL, IQR=93-143), regardless of CC depth. The figure illustrates a typical tracing in which ventilation volume dwarfs any passive ventilation occurring with CC. Conclusion: Late in CA, passive ventilation occurring during CCs appears to produce considerably less gas exchange than calculated dead space. The effectiveness of passive ventilation during early stages of CPR, when chest and lung compliance are greater, remains unknown. However, these findings suggest that the benefits of COCPR strategies may be related to reliably higher CC fraction and/or prevention of the negative effects of hyperventilation rather than from any passive ventilation.
Abstract 18901: Direct Evidence that a KCNQ1 Mutation is Linked to Familial Early-onset Atrial Fibrillation
Anderson, Jeffrey , Johnson, Jonathan N. , Tester, David J. , Burgess, Don E. , Homfray, Tessa , Ackerman, Michael J. , Bartos, Daniel C. , Bastiaenen, Rachel , Gollob, Michael H. , Behr, Elijah Raphael , Guicheney, Pascale , Delisle, Brian P.

Mayo Clinic

Circulation | April 23, 2024 | Volume: 126 | Issue: suppl_21 | Pages: No page available

10.1161/circ.126.suppl_21.a18901 Get It

KCNQ1 encodes the voltage-gated α-subunit of the I Ks channel complex (Kv7.1), and KCNQ1 mutations are associated with multiple arrhythmia syndromes. Over the past 12 years, hundreds of different KCNQ1 mutations have been linked to congenital long QT syndrome but only three KCNQ1 variants, each identified in only one family, are linked to familial early-onset AF (<50 years of age). The scant genetic linkage between KCNQ1 and early-onset AF raises the question as to whether these KCNQ1 variants actually cause familial early-onset AF or simply unmask a latent genetic predisposition. We now report that a single KCNQ1 variant, pArg231His or R231H, is identified in five unrelated families with a high penetrance of familial early-onset AF. Whole-cell patch clamp of cells heterologously expressing the obligatory I Ks β-subunit KCNE1 with wild-type KCNQ1 (WT) or WT and R231H (to mimic the patients’ genotypes) showed that cells co-expressing R231H increased current at negative and resting membrane potentials. Additionally, currents recorded from cells using a human atrial action potential (AP) waveform at physiological temperature showed that WT is minimally activated during the atrial AP and co-expression of R231H increases current measured during the atrial AP waveform by greater than 20-fold (WT, n = 10; WT & R231H, n = 12, p<0.0001). Simulations using a computational model of a human atrial AP also predicted that I Ks is normally minimally activated in the atria and R231H would dramatically increase I Ks and shorten the atrial AP. We conclude that KCNQ1 mutations are capable of causing familial early-onset AF by increasing I Ks during the atrial AP and shortening atrial refractoriness.
Abstract 9243: Comparison of the 2006 and 2010 Appropriate Use Criteria for CT Coronary Angiography in an Academic Medical Center
Cullen, Ethany L., Aggarwal, Shivani , Goss, Brian C., Araoz, Philip A. , Gibbons, Raymond J.

Mayo Clinic

Circulation | April 23, 2024 | Volume: 124 | Issue: suppl_21 | Pages: No page available

10.1161/circ.124.suppl_21.a9243 Get It

Purpose: We previously analyzed the 2006 appropriateness criteria for cardiac computed tomography (CT) and found 42% of our patients were not classifiable, suggesting the criteria were difficult to apply clinically. These criteria were revised in 2010. The purpose of our study is to compare the new 2010 appropriate use criteria to the original 2006 criteria to determine if the 2010 criteria were more applicable. Materials and Methods: In a previous study we applied the 2006 appropriateness criteria to 251 patients that underwent cardiac CT from June 1 to December 31, 2007. Each patient was assigned an indication from the 2006 appropriate use criteria by two observers, classifying patients as appropriate, inappropriate, uncertain, or nonclassifiable. A third observer settled disagreements. This process was applied to the same 251 patients using the 2010 criteria. The data from the previous study using the 2006 criteria was compared to the data obtained using the 2010 criteria to determine changes in the number of nonclassifiable, appropriate, inappropriate, and uncertain exams. These results were then analyzed using Bowker's test of symmetry. Observer agreement was calculated using the kappa statistic. Results: 115 patients (46%) were not classifiable using the 2006 criteria. When the 2010 criteria were applied, the number of not classifiable patients decreased to 40 (16%), with the plurality, 41 (16%), of the not classifiable patients moving to inappropriate. In 2006, 69 (27%) were classified as appropriate, 25 (10%) were uncertain, 42 (17%) inappropriate. In 2010, the appropriate increased to 84 (33%), uncertain increased to 40 (16%), and inappropriate increased to 87 (35%). Bowker's test of symmetry demonstrated a statistically significant change with a p<0.001. Agreement between the two observers assigning patients to classification groups also improved with a kappa of 0.55 using the 2010 criteria compared to kappa of 0.31 in 2006. Conclusion: The number of not classifiable patients decreased using the 2010 criteria and the interobserver agreement improved, suggesting they are more applicable and complete than the 2006 criteria. This decrease in not classifiable patients came primarily from an increase in the number of inappropriate indications.
The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder
Cameron, Anne P., Chung, Doreen E. , Dielubanza, Elodi , Enemchukwu, Ekene , Ginsberg, David A. , Linder, Brian J. , Rovner, Eric S., Souter, Lesley , Welk, Blayne , Cameron, Anne P. , Linder, Brian J , Helfand, Brian T. , Reynolds, William M. , Suskind, Anne M. , Takacs, Elizabeth B. , Smith, Ariana L.

Mayo Clinic

Journal of Urology | April 23, 2024 | Volume: 212 | Issue: 1 | Pages: 11-20

10.1097/ju.0000000000003985 | PMID 38651651 Get It

Most Promising Approaches to Improve Brain AVM Management: ARISE I Consensus Recommendations
Samaniego, Edgar A. , Dabus, Guilherme , Meyers, Philip M. , Kan, Peter , Frösén, Juhana , Lanzino, Giuseppe , Welch, Babu G. , Gonzalez, L. Fernando , Fifi, Johanna T , Charbel, Fady T. , Khalessi, Alexander A. , Marks, Michael P. , Berenstein, Alejandro , Pereira, V Mendes, Bain, Mark, Narayanan, Sandra , Tateshima, Satoshi , Siddiqui, Adnan H. , Wakhloo, Ajay K. , Lawton, Michael T. , Kan, Peter , Volovici, Victor , Gonzalez, Fernando , Fifi, Johanna T , Hoh, Brian L , Berenstein, Alejandro , Colby, Geoffrey P , Narayanan, Sandra , Tateshima, Satoshi , Siddiqui, Adnan H , Wakhloo, Ajay K , Arthur, Adam Stephen , Lawton, Michael T , Samaniego, Edgar A , Lanzino, Giuseppe , Welch, Babu , Dabus, Guilherme C. , Volovici, Victor , Hoh, Brian L. , Colby, Geoffrey P.

Mayo Clinic

Stroke | April 22, 2024 | Volume: 55 | Issue: 5 | Pages: 1449-1463

10.1161/strokeaha.124.046725 | PMID 38648282 Get It

Brain arteriovenous malformations (bAVMs) are complex, and rare arteriovenous shunts that present with a wide range of signs and symptoms, with intracerebral hemorrhage being the most severe. Despite prior societal position statements, there is no consensus on the management of these lesions. ARISE (Aneurysm/bAVM/cSDH Roundtable Discussion With Industry and Stroke Experts) was convened to discuss evidence-based approaches and enhance our understanding of these complex lesions. ARISE identified the need to develop scales to predict the risk of rupture of bAVMs, and the use of common data elements to perform prospective registries and clinical studies. Additionally, the group underscored the need for comprehensive patient management with specialized centers with expertise in cranial and spinal microsurgery, neurological endovascular surgery, and stereotactic radiosurgery. The collection of prospective multicenter data and gross specimens was deemed essential for improving bAVM characterization, genetic evaluation, and phenotyping. Finally, bAVMs should be managed within a multidisciplinary framework, with clinical studies and research conducted collaboratively across multiple centers, harnessing the collective expertise and centralization of resources.
0611 Gamification of Digital Oropharyngeal Exercises Improves Therapy Adherence in OSA Patients
Goswami, Umesh , Krohn, Brian, Goswami, Umesh

Mayo Clinic

SLEEP | April 20, 2024 | Volume: 47 | Issue: Supplement_1 | Pages: A261-A261

10.1093/sleep/zsae067.0611 Get It

Abstract Introduction OSA is caused by the interaction of impaired upper airway anatomy and dysfunctional upper airway muscle response to airway narrowing during sleep. Oropharyngeal exercises focused on training upper airway muscles are effective in reducing OSA severity and symptoms. However, similar to other physical therapy programs, oropharyngeal exercises require patients to complete multiple therapy sessions which affects patient compliance. To address this, we developed a smartphone application to provide oropharyngeal exercise and tested the effect of adding gamification and habit formation techniques on therapy adherence. Methods The experimental app which included oropharyngeal exercise therapy administered using voice-controlled games, a reward system, a reminder system, and supportive video content was compared to the control app that included text-based exercise therapy instructions and limited video content. Participants with mild to moderate OSA were randomly assigned (1:1) to either group. Demographics, sleep apnea variables, therapy progress, self-reported snoring severity questionnaires were collected for both groups. Appropriate descriptive statistics were used to summarize baseline and outcome data. Results 30 participants (13 male), mean age 60.7 ± 11.1 years were randomized equally to the experimental and control groups. 9 participants (6 in the experimental group and 3 in the control group) were unable to complete the study due to technical challenges with the apps and were excluded from analysis. No statistically significant differences were noted in either group’s baseline demographic and OSA measures. 7/9 (78%) participants in the experimental group vs 7/12 (58%) in the control group met the prespecified compliance thresholds for the 8 weeks therapy period. Self-reported snoring severity mean scores were significantly reduced in the experimental group (from 2.86 to 1.43, p-value 0.04) compared to the control group (from 2.14 to 1.77, p-value 0.21). Conclusion Addition of gamification and therapy monitoring techniques improve compliance to the prescribed oropharyngeal exercises in patients with OSA. Further studies are needed to establish the efficacy of gamified oropharyngeal therapy in the treatment of OSA. Support (if any) Research reported in this abstract was supported by NHLBI of the NIH under award number: R43HL152948-01.